Bonesupport Holding Ab · OMXSTO:BONEX

Bonesupport Holding Ab — Q2 2026 Earnings Presentation

16 slides from Bonesupport Holding Ab's earnings presentation, Jul 16, 2026

  1. Slide 1: BONESUPPORT Q2 (2026) Report

    BONESUPPORT Q2 (2026) Report July 16, 2026 Torbjörn Sköld, CEO Håkan Johansson, CFO

  2. Slide 2: Disclaimer

    DISCLAIMER This presentation contains forward-looking statements regarding BONESUPPORT HOLDING AB (publ) (“BONESUPPORT”), including, but not limited to, statements about future operations, financial performance, market conditions, growth strategies, product development, regulatory approvals, and oth

  3. Slide 3: Second quarter report 2026: Financial and operational highlights

    BONESUPPORT – Second quarter report 2026 Financial highlights • Net sales SEK 355.7 m (SEK 284.4 m) Sales growth at constant exchange rates (CER): +30% Reported growth: +25% versus Q2 2025 • Operating results: Adjusted Operating result1: SEK 104.1 m (SEK 62.4 m), resulting in adj. Operating margin o

  4. Slide 4: Continued strong momentum for CERAMENT G in the US

    Continued strong momentum for CERAMENT G in the US LTM Reported Net sales (SEK m) by Segment and Quarter 1,375 1,286 1,250 1,215 • LTM growth of 32% in constant currencies, 1,175 1,119 versus 21% in the graph (reported) 1,125 1,062 1,000 998 • US CERAMENT BVF (LTM) flat in Q2 2026 899 compared to Q2

  5. Slide 5: US: Increasing customer access and adoption for CERAMENT G

    US: Increasing customer access and adoption for CERAMENT G Q2 2026 • Sales of SEK 295.2 m (SEK 235.6 m). Growth of 25% over Q2 2025 • Growth of 31% at CER Highlights • Growth of CERAMENT G: • Adoption (existing accounts & surgeons) – short term influenced by pre-approvals in a handful of accounts •

  6. Slide 6: EUROW: Strong growth across markets

    EUROW: Strong growth across markets Q2 2026 • Sales of SEK 60.5 m (SEK 48.8 m), growth of 24% over Q1 2025 • Growth of 26% at CER • Strong growth, even adjusting for the soft prior-year base Highlights • Direct Markets delivered at solid growth rates with continued Germany recovery • Hybrid markets

  7. Slide 7: Financial Report

    BONESUPPORT Q2 (2026) Report Financial Report

  8. Slide 8: Q2 Net sales growth reached 30% in CER

    Q2 Net sales growth reached 30% in CER Q2 Net sales vs PY Increase Decrease Total 400.0 13 72 356 • US growth reported at 25% 350.0 -13 (31% in CER). 300.0 284 • EUROW growth reported at 24% 250.0 Net sales, SEKm (26% in CER). 200.0 150.0 100.0 50.0 0.0 Org growth US fx Q2 2025 Org growth EUROW Q2 2

  9. Slide 9: Continued strong CG performance in the US

    Continued strong CG performance in the US Sales CERAMENT G - US per quarter • Strong access and adoption 30 450 largely compensating isolated 400 headwinds with a handful of Net sales per working day, USDk 25 350 established customers in Q2. Net sales, USDm 20 300 250 15 200 10 150 100 5 50 0 0 Q4 2

  10. Slide 10: US and EUROW net sales and gross margin

    +25% +24% (+31% CER) (+26% CER) US Net sales Q2-26 EUROW Net sales Q2-26 North America 2026 2025 EUROW 2026 2025 SEKm Q2 Q1 Q4 Q3 Q2 SEKm Q2 Q1 Q4 Q3 Q2 Net Sales 295.2 267.1 258.8 246.3 235.6 Net Sales 60.5 56.9 53.8 47.8 48.8 Gross profit 276.9 252.3 245.3 234.8 223.1 Gross profit 48.8 46.5 43.6 3

  11. Slide 11: Commercial investments increasing selling expenses

    Commercial investments increasing selling expenses Key Figures 2026 2025 2024 SEKm Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3 Selling expenses 83.4 84.5 79.8 66.3 67.2 73.0 71.2 65.5 Sales Commissions and fees 95.3 85.7 85.6 85.1 79.4 79.3 70.4 65.5 Research and Development expenses 24.8 25.1 23.5 20.6 23.6 23.8 21.8

  12. Slide 12: Continued strong operating leverage and cash conversion

    Continued strong operating leverage and cash conversion Key Figures 2026 2025 2024 SEKm Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3 Net sales 355.7 324.0 312.5 294.1 284.4 283.5 257.0 237.5 Gross margin (%) 90.8 92.2 92.5 92.9 92.3 92.6 92.6 92.9 Operating profit 89.6 72.2 81.8 65.4 54.9 29.6 64.2 41.0 Adj. Operating p

  13. Slide 13: Solid operating margin improving after a period of commercial investments

    Solid operating margin improving after a period of commercial investments 120 11.25 105 11.00 Adjusted operating result (1) in SEKm 90 10.75 75 10.50 USD rate 60 10.25 45 10.00 30 9.75 15 9.50 0 9.25 Q3-23 Q4-23 Q1-24 Q2-24 Q3-24 Q4-24 Q1-25 Q2-25 Q3-25 Q4-25 Q1-26 Q2-26 USD Rate Adjusted operating

  14. Slide 14: Continued solid cash flows

    Continued solid cash flows Cash flows from operating activities 100 140% Cash conversion1 between Cash flows from operating activities, SEKm 64-126 % from Q3 2024 and 80 120% onwards - Average 79% Cash conversion 60 100% 40 80% 20 60% 0 40% 24 Q3 24 Q4 25 Q1 25 Q2 25 Q3 25 Q4 26 Q1 26 Q2 Cash flow f

  15. Slide 15: BONESUPPORT Q2 (2026) Report summary and updated guidance

    BONESUPPORT Q2 (2026) Report • 30% Net sales growth at CER • EUROW sales growth 26% at CER • Operating margin of 29% • Cash flows SEK 67 m, share buy back of SEK 82.9 m and cash position SEK 434 m • CERAMENT V De Novo application progress Updated Guidance: Net sales growth 33% to 36% (CER) for FY 20

  16. Slide 16: BONESUPPORT

    § BONESUPPORT

Bonesupport Holding — Q2 2026 Earnings Presentation on 6ix